Tris launches promethazine and codeine syrup
Tris Pharma has announced the introduction of its promethazine and codeine syrup (promethazine HCl and codeine phosphate oral solution. The product is manufactured at the company’s facility in Monmouth Junction, N.J.
Tris’ promethazine and codeine syrup will be available in 16-oz. bottles in dosage strengths of 6.25 mg and 10 mg per 5-ml oral solution. The drug is indicated for temporary relief of coughs and uppers respiratory system associated with allergies or the common cold in patients 18 years of age and older. The drug’s market size was for the 12 months ended December 2017 was roughly $8 million, according to IQVIA data.
FDA approves Lupin’s generic Topicort spray
The Food and Drug Administration has approved Lupin’s generic Topicort (desoximetasone topical spray, 0.25%). The drug is a corticosteroid indicated to treat plaque psoriasis in patients ages 18 years and older.
Lupin’s generic Topicort spray will be available in 30-, 50- and 100-ml. The product had U.S. sales of roughly $19.5 million for the 12 months ended January 2018, according to IQVIA data.
CVS Pharmacy offers Shingrix nationwide
CVS Health’s retail division is offering patients at all of its more than 9,800 pharmacy locations the recently approved shingles vaccine Shingrix. The Woonsocket, R.I.-based company said that the vaccine is now recommended by the Centers for Disease Control and Prevention for patients ages 50 years and older.
Shingrix is considered more than 90% effective at preventing shingles, CVS Health said, noting that patients are recommended to receive two doses of the vaccine, two-to-six months apart.
“Vaccination is key to preventing shingles and CVS Pharmacy is pleased to be able to provide patients with convenient access to this new and more effective vaccine,” said Kevin Hourican CVS Pharmacy executive vice president of pharmacy services. “Our pharmacists can help patients determine if Shingrix is right for them and can vaccinate patients at times and locations that work for their busy schedules.”
CVS health said that many health plans, including Medicare Part D plans, will cover the vaccine.